Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04213950 · ClinicalTrials.gov registry record · NA
Improving Adherence to Rabies PEP Guideline Recommendations
A NA study, sponsored by The Methodist Hospital Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT04213950 is a NA study that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 70 participants.
The verdict
NCT04213950, a NA study, has completed, sponsored by The Methodist Hospital Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This quasi-experimental, quality improvement study will be conducted across the Houston Methodist system, including all hospital-based and freestanding emergency departments (ED). Previous research identified opportunities to improve patient selection and delivery of rabies immune globulin (IG) as recommended by Centers for Disease Control and Prevention (CDC) guideline recommendations for rabies postexposure prophylaxis (PEP). The purpose of this study is to develop, implement, and measure the impact of a quality improvement bundle that consists of (1) rabies PEP electronic health records (EHR) enhancements, (2) education to ED staff, and (3) education to patients. Adherence to quality indicators, which are based on CDC guideline recommendations, for patient selection and delivery of rabies IG for 12 months following implementation (post-implementation group) will be compared with a historical control group.
Interventions
- OTHER Rabies PEP quality improvement bundle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2019-12-29 |
| Est. Completion | 2020-12-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04213950
The ClinicalTrials.gov registry entry for NCT04213950 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rabies PEP quality improvement bundle is the first listed.
NCT04213950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04213950 about?
NCT04213950 is a clinical study titled "Improving Adherence to Rabies PEP Guideline Recommendations". This quasi-experimental, quality improvement study will be conducted across the Houston Methodist system, including all hospital-based and freestanding emergency departments (ED). Previous research identified opportunities to improve patient selection and delivery of rabies immune globulin (IG) as r...
What is the current status of trial NCT04213950?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2019-12-29. Estimated completion is 2020-12-23.
What interventions are being tested in trial NCT04213950?
The interventions under investigation include: Rabies PEP quality improvement bundle (OTHER).
Who is sponsoring clinical trial NCT04213950?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.